• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 11500A
Device Problem Inadequacy of Device Shape and/or Size (1583)
Patient Problem Great Vessel Perforation (2152)
Event Date 10/06/2021
Event Type  Injury  
Event Description
Edwards received information a 23mm 11500a aortic valve was explanted at implant due to sizing.It was reported the surgeon went to implant the 23mm 11500a and had difficulty passing the valve into the annulus.Medical records noted as the 23mm 11500a was passing through the sinotubular junction, the aorta tore.The aorta was noted to be very friable.The 23mm valve was removed and replaced with a 21mm 11500a aortic valve as surgeon was concerned about further disruption of the sinus.Device is available for return.Patient did well.The patient remained intubated and was transferred to the cv recovery unit.Patient was discharged home in stable condition on post-operative day eight (8).
 
Manufacturer Narrative
As received, valve was still attached to holder with all three green sutures intact at the cutting channels.The x-ray demonstrated the wireform and cocr band remained intact; the vfit cocr alloy band was not expanded.No visible inconsistencies were observed on the valve.Suture holes were observed around the sewing ring.The device was returned for evaluation.Customer report of sizing issues could not be confirmed through visual observations.A supplemental mdr will be submitted as soon as additional information becomes available.The cause of the event cannot be determined at this time.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Manufacturer Narrative
H3.Device evaluation: the external sewing ring diameter measured to be approximately 29 mm and the internal stent diameter measured to be approximately 22 mm.The device history record was reviewed and shows that this device met all manufacturing specifications for product release prior to distribution.No issues were identified that would have impacted this event.The cause of the event was most likely related to procedural factors.
 
Manufacturer Narrative
H10.Additional manufacturer narrative: measurements performed in product evaluation align with nominal measurements provided in the ifu.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS INSPIRIS RESILIA AORTIC VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer Contact
reginald santos
1 edwards way
irvine, CA 92614
9492502731
MDR Report Key12791673
MDR Text Key283680530
Report Number2015691-2021-06248
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 01/12/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number11500A
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/01/2021
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 10/06/2021
Initial Date FDA Received11/10/2021
Supplement Dates Manufacturer Received01/05/2022
01/12/2022
Supplement Dates FDA Received01/05/2022
01/12/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/22/2021
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age75 YR
Patient SexFemale
Patient Weight83 KG
-
-